With many point-of-care HbA1c testing facilities closing their doors due to the COVID-19 pandemic, many people living with diabetes were unable to have their HbA1c tested. A full year of uncontrolled diabetes is not benign and could affect life expectancy.1 Let’s get patients back to the point of care and provide important HbA1c testing.
Point-of-care testing has proven more effective in reducing HbA1c than other testing methods. Face-to-face counseling enables education, helps to engage patients, and leads to increased compliance.
The Atellica DCA Analyzer is a compact, portable, and fully customizable POC diabetes testing system that puts fast, quality results right at your fingertips.
A simplified user interface can minimize training time and provide patients with timely test results
Did this information help you?
Not available for sale in the U.S. Product availability varies by country.